El Jian BOTOX approves 10th indication

Common causes of spasms in children include cerebral palsy, traumatic brain injury, multiple sclerosis, spinal cord injury, and stroke, a group of diseases that affect an individual's ability to move and maintain balance and postureSpasms manifest themselves as muscle tension and stiffness, with moderate to severe degreesUpper limb spasms in children can significantly affect their development and quality of life, especially when children in the growth and development are very weak, forcing them to require constant careThese children need new treatment options to help them relieve spasms, thereby improving mobility and quality of lifeBotox toxin is a neurotoxin, it acts on choline motor nerve endings, the role of anti-calcium ions, interferes with the release of acetylcholine from motor nerve endings, promotes muscle fibers can not contract, and thus reduces muscle tone, relieves spasmsThe BOTOX developed by El Jian is a type A Botox toxin that has been approved for treatment since its launch in 1989, including eyelid spasms and squint, upper, lower limb spasms, chronic migraines, neurotic urinary incontinence, bladder hyperactivity syndrome and other indicationsBOTOX's long and well-established safety and efficacy record makes it an important treatment option for childrenboTOX's mechanism of action (photo: Botox official website)this indication is based on two Phase 3 clinical trials involving more than 200 children with upper limb spasms, including a 12-week double-blind trial and a year-long open label trialDr David Nicholson, chief research officer at, said: "It is sad to see children suffering from any degree of upper limb spasmsThis FDA approval is of special significance to El Jian because we can now offer BOTOX as a treatment option for these children and their familiesThe approval is also another milestone since BOTOX was approved in 1989 to treat eyelid spasms and squintThis is inextricably linked to ElJian's continued innovative spirit and boTOX's 30 years of relentless research and development investmentReferences:.®Retrieved June 21, 2019, from https://Retrieved June 21, 2019, from https://original title: Courier - 30 years of "old medicine" rejuvenated, El Jian BOTOX approved 10th indication